🇺🇸 FDA
Patent

US 9968631

Method for treatment of pulmonary fibrosis

granted A61KA61K31/715A61K31/736

Quick answer

US patent 9968631 (Method for treatment of pulmonary fibrosis) held by GALECTIN THERAPEUTICS, INC. expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GALECTIN THERAPEUTICS, INC.
Grant date
Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/715, A61K31/736